Nonalcoholic Steatohepatitis
📧 Sign up to get email alerts when something new happens for Nonalcoholic Steatohepatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-21Clinical Trial Results: A Study of Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (Symmetry) [Phase 2]
Phase 2 study results for efruxifermin in patients with compensated cirrhosis due to NASH have been completed and results posted.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral Therapy
A National Institute of Allergy and Infectious Diseases-sponsored trial evaluating liver fibrosis and steatohepatitis in HIV-infected patien…
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Effectiveness of Endoscopic Sleeve Gastroplasty in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
This clinical trial from West Virginia University assesses the effectiveness of endoscopic sleeve gastroplasty for nonalcoholic fatty liver …
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH [Phase 3]
A Phase 3 trial evaluating efruxifermin in adults with compensated cirrhosis due to NASH/MASH is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Novel MRE Technique to Assess a Risk Factor for Liver Cancer
A clinical trial is evaluating a novel magnetic resonance elastography technique as a potential tool to assess a risk factor for liver cance…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-22Clinical Trial Update: A Randomized Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese Patients [NA]
A randomized controlled trial evaluating bariatric surgery as a treatment for severe nonalcoholic steatohepatitis with advanced liver fibros…
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH) [Phase 2]
This is a Phase 2b clinical trial update on Miricorilant for nonalcoholic steatohepatitis/metabolic dysfunction-associated steatohepatitis (…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Digital Therapy for Fatty Liver Disease [NA]
This clinical trial update indicates an active but not recruiting study of a digital therapy for nonalcoholic fatty liver disease and nonalc…
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease
This completed study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) evaluated the response to COV…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Safety and Efficacy of Ketogenic Diet for Promoting Weight Loss in Obese Individuals With Compensated NASH Cirrhosis [NA]
This clinical trial is evaluating the safety and efficacy of a ketogenic diet to promote weight loss in obese adults with compensated nonalc…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis [Phase 3]
Akero Therapeutics is conducting a Phase 3 trial of efruxifermin in adults with noncirrhotic NASH/MASH with fibrosis; recruitment is ongoing…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH [Phase 3]
GlaxoSmithKline is conducting a Phase 3 pivotal trial to evaluate Efimosfermin Alfa in participants with biopsy-confirmed F2- or F3-stage MA…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study to Assess the Safety, Pharmacokinetics, and Activity of RO7790121 in Participants With Advanced MASH Liver Fibrosis [Phase 1]
This Phase 1 study evaluates the safety, pharmacokinetics, and activity of RO7790121 in participants with advanced nonalcoholic steatohepati…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Androgens and NAFLD Longitudinal Cohort Study
A longitudinal cohort study sponsored by University of California, San Francisco investigating the relationship between androgens and NAFLD/…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: RE and Probiotics in MAFLD/NAFLD [NA]
Clinical trial update from Nicolaus Copernicus University evaluating RE and probiotics for metabolic dysfunction-associated fatty liver dise…
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Feasibility, Safety and Acceptability of a Mobile Health Delivered Exercise Training Program in Patients With Nonalcoholic Steatohepatitis [NA]
A completed clinical trial evaluated the feasibility, safety, and acceptability of a mobile health-delivered exercise training program in pa…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Semaglutide vs Sitagliptin [Phase 4]
Phase 4 clinical trial comparing semaglutide and sitagliptin in liver transplant recipients with diabetes and fatty liver disease. Enrollmen…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced Fibrosis
This ClinicalTrials.gov entry describes a study assessing outcomes in nonalcoholic steatohepatitis with advanced fibrosis, currently recruit…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Characterization of Immune Semaphorin in Non Alcoholic Fatty Liver Disease and NASH [NA]
This clinical trial update indicates completion of a study characterizing immune semaphorin in non-alcoholic fatty liver disease and nonalco…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)
A longitudinal observational study across the full spectrum of nonalcoholic fatty liver disease, including nonalcoholic steatohepatitis, is …
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 ) [Phase 3]
Phase 3 study evaluating the efficacy and safety of lanifibranor in adults with nonalcoholic steatohepatitis and fibrosis stages F2-F3 (NATi…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Study to Evaluate the Efficacy and Safety of K-877-ER and CSG452 in Participants With NASH With Liver Fibrosis [Phase 2]
A Phase 2 study to evaluate the efficacy and safety of K-877-ER and CSG452 in participants with nonalcoholic steatohepatitis (NASH) with liv…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Vitamin E Dosing Study [Phase 2]
A Phase II trial evaluating different dosing regimens of vitamin E for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis has…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Phase 2b Study of GSK4532990 in Adults With NASH [Phase 2]
Phase 2b trial update for GSK4532990 in adults with nonalcoholic fatty liver disease, specifically nonalcoholic steatohepatitis (NASH). The …
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Effect of Patient Demographics, Comorbidities, and Medications on Severity of NASH Fibrosis
A completed clinical trial evaluating how patient demographics, comorbidities, and concomitant medications influence the severity of fibrosi…